Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Kaleido Biosciences to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis

Kaleido Biosciences 12.12.2019

Kaleido Biosciences Appoints William Duke as Chief Financial Officer

Kaleido Biosciences 11.06.2019

Kaleido Biosciences and Washington University School of Medicine to Collaborate on Exploring the Influence of Microbiome Metabolic Therapies (MMT™) on Physiology and Metabolism

Kaleido Biosciences 10.22.2019

Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019™

Kaleido Biosciences 10.03.2019

Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors

Kaleido Biosciences 09.30.2019

Kaleido Biosciences Announces CFO Transition

Kaleido Biosciences 09.26.2019

Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT™) in Immuno-oncology

Kaleido Biosciences 09.09.2019

Kaleido Biosciences Presents Data from Clinical Study of KB195 in Patients with Urea Cycle Disorders at Society for the Study of Inborn Errors of Metabolism Annual Symposium

Kaleido Biosciences 09.03.2019

Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary

Kaleido Biosciences 07.22.2019

Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors

Kaleido Biosciences 07.15.2019

Loading